Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0000905148-26-004080

EVP & Chief Financial Officer acquired 4,600 shares (option exercise)

  • EVP & Chief Financial Officer gave up 928 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Schorno Dean L · EVP & Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-01 Shares withheld for taxes : show line 1 in the form −928 $47.50 $44,080 78,362 D
2026-09-02 Exercise or conversion : show line 2 in the form +694 $12.70 $8,814 79,056 D
2026-09-02 Exercise or conversion : show line 3 in the form +620 $18.70 $11,594 79,676 D
2026-09-02 Exercise or conversion : show line 4 in the form +2,000 $24.20 $48,400 81,676 D
2026-09-02 Exercise or conversion : show line 5 in the form +1,286 $24.20 $31,121 82,962 D

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2026-09-02 Exercise or conversion : show line 6 in the form Employee Stock Option (right to buy) −694 12,824 D
2026-09-02 Exercise or conversion : show line 7 in the form Employee Stock Option (right to buy) −620 9,012 D
2026-09-02 Exercise or conversion : show line 8 in the form Employee Stock Option (right to buy) −2,000 7,999 D
2026-09-02 Exercise or conversion : show line 9 in the form Employee Stock Option (right to buy) −1,286 15,867 D
Loading xslF345X06/form4.xml…